NEWS
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! The 2025 Edition of the AD Scientific Index is now live!
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
"Exciting Update! The 2025 Edition of the AD Scientific Index is now live!
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Top Lists
Joel E Lavine
Columbia University New York - New York City / United States
Medical and Health Sciences / Pediatrics and Child Health
AD Scientific Index ID: 911281
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Joel E Lavine's MOST POPULAR ARTICLES
1-)
The diagnosis and management of non‐alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of …N Chalasani, Z Younossi, JE Lavine, AM Diehl, EM Brunt, K Cusi, ...Hepatology 55 (6), 2005-2023, 201244702012
2-)
The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver DiseasesN Chalasani, Z Younossi, JE Lavine, M Charlton, K Cusi, M Rinella, ...Hepatology 67 (1), 328-357, 201844182018
3-)
Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitisAJ Sanyal, N Chalasani, KV Kowdley, A McCullough, AM Diehl, NM Bass, ...New England Journal of Medicine 362 (18), 1675-1685, 201032352010
4-)
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trialBA Neuschwander-Tetri, R Loomba, AJ Sanyal, JE Lavine, ML Van Natta, ...The Lancet 385 (9972), 956-965, 201524602015
5-)
The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of …N Chalasani, Z Younossi, JE Lavine, AM Diehl, EM Brunt, K Cusi, ...Gastroenterology 142 (7), 1592-1609, 201221462012
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept